Association between HbA
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
accepted:
28
01
2019
pubmed:
31
1
2019
medline:
4
9
2020
entrez:
31
1
2019
Statut:
ppublish
Résumé
To examine HbA A 7-year retrospective longitudinal study was conducted in 50 adults with cystic fibrosis, comparing oral glucose tolerance test results with HbA An HbA There is a link between HbA
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin A
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1251-1255Informations de copyright
© 2019 Diabetes UK.
Références
Milla CE, Warwick WJ, Moran A. Trends in Pulmonary Function in Patients with Cystic Fibrosis Correlate with the Degree of Glucose Intolerance at Baseline. Am J Respir Crit Care Med 2016; 162: 891-895.
Hameed S, Morton JR, Jaffe A, Field PI, Belessis Y et al. Early glucose abnormalities in cystic fibrosis are preceeded by poor weight gain. Diabetes Care 2010; 33: 221-226.
Courtney JM, Bradley J, Mccaughan J, O'Connor TM, Shortt C, Bredin CP, Bradbury I, Elborn JS. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol 2007; 42: 525-537.
Bridges N, Rowe R, Holt RIG. Unique challenges of cystic fibrosis-related diabetes. Diabet Med 2018; 35: 1181-1188.
UK Cystic Fibrosis Trust Diabetes Working Group. Management of Cystic Fibrosis related Diabetes Mellitus. Report of the UK Cystic Fibrosis Trusts Diabetes Working Group. 2nd floor, One Aldgate, London, 2004. Available at https://www.cysticfibrosis.org.uk/~/media/&/the-work-we&/cfrd-mellitus.ash. Last accessed 8 May 2018.
World Health Organisation. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia, 2006. Available at https://www.who.int/diabetes/publications/en. Last accessed 23 January 2018.
Leclercq A, Gauthier B, Rosner V, Weiss L, Moreau F, Constantinescu AA et al. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients. J Cyst Fibros 2013; 13: 478-484.
Sterescu AE, Rhodes B, Jackson R, Dupuis A, Hanna A, Wilson DC et al. Natural history of glucose intolerance in patients with cystic fibrosis: ten year prospective observation programe. J Pediatr 2010; 156: 613-617.
Waugh N, Royle P, Craigie I, Ho V, Pandit L, Ewings P et al. Screening for cystic fibrosis-related diabetes: a systematic review. Health Technol Assess 2012; 16: 1-179.
Gifford AH, Miller SD, Jackson BP, Hampton TH, O'Toole GA, Statpn BA et al. Iron and CF-Related Anemia: Expanding Clinical and Biochemical Relationships. Pediatr Pulmonol 2011; 46: 160-165.
Burgess JC, Bridges N, Banya W, Gyi KM, Hodson ME, Bilton D et al. HbA1c as a screening tool for cystic fibrosis related diabetes. J Cyst Fibros 2016; 15: 251-257.
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a multivariant prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Diabet Med 2015; 32: 146-154.
Boudreau V, Coriati A, Desjardins K, Rabasa-Lhoret R. Glycated hemoglobin cannot be proposed as a screening tool for cystic fibrosis related diabetes. J Cyst Fibros 2016; 15: 258-260.
Holl RW, Buck C, Babka, Wolf A, Thon A. HbA1c Is Not Recommended as screening test for Diabetes in Cystic Fibrosis. Diabetes Care 2000;23:126.
Brennan AL, Gyi KM, Wood DM, Hodson ME, Geddes DM, Baker H. Relationship between glycosylated haemoglobinand mean plasma glucose concentration in cystic fibrosis. J Cyst Fibros 2006; 5: 27-31.
Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J et al. Insulin therapy to improve BMI in cystic fibrosis related diabetes without fasting hyperglycaemia. Diabetes Care 2009; 32: 1783-1788.
Hameed S, Morton JR, Field PI, Belessis Y, Yoong T, Katz T et al. Once daily insulin detemir in cystic fibrosis with insulin deficiency. Arch Dis Child 2011; 97:1-4.
Roberts R, Speight L, Lee J, George L, Ketchell RI, Lau D et al. Retinal screening of patients with cystic fibrosis-related diabetes in Wales-A real eye opener. J Cyst Fibros 2015; 14: 282-284.
Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C et al. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 2007; 30: 1056-1061.
Gilchrist FJ, Bright-Thomas RJ, Webb AK, Jones AM, Rowe R. Diabetic retinopathy in patients who do not meet the diagnostic crieria for cystic fibrosis related diabetes. Pract Diabetes 2015; 32: 333-335a.